The Biomedical Research Council of Singapore (ASTAR) has awarded a Therapeutics Development Review Grant (TDR) to Carlos Ibanez for investigations into novel drug discovery methods targeting receptor transmembrane domains.
|
|||||
|
The Saturday edition of the The Straits Times publishes today an interview with Carlos Ibanez highlighting the identification a small molecule targeting the transmembrane domain of death receptor p75NTR that induces melanoma cell death and reduces tumor growth (reported in our paper published in Cell Chemical Biology). Read the full article here. Also newspaper Lianhe Zaobao (Chinese Daily) carried a story (in Chinese) on the discovery. |
RhoGDI interaction to p75NTR |
|
|||
